Phathom Pharmaceuticals (PHAT) Capital Expenditures Growth (1y) (2020 - 2025)
Phathom Pharmaceuticals (PHAT) Capital Expenditures Growth (1y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Phathom Pharmaceuticals |
895.99 Mn |
712.23 Mn |
46.31 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
3,460.00% |
| Sep 30, 2025 |
-153.33% |
| Jun 30, 2025 |
3,133.33% |
| Mar 31, 2025 |
157.14% |
| Dec 31, 2024 |
100.44% |
| Sep 30, 2024 |
-87.22% |
| Jun 30, 2024 |
-50.00% |
| Mar 31, 2024 |
-96.73% |
| Dec 31, 2023 |
-132.38% |
| Sep 30, 2023 |
53.18% |
| Jun 30, 2023 |
105.77% |
| Mar 31, 2023 |
78.33% |
| Dec 31, 2022 |
-253.92% |
| Sep 30, 2022 |
399.02% |
| Jun 30, 2022 |
-153.89% |
| Mar 31, 2022 |
471.43% |
| Dec 31, 2021 |
-68.13% |
| Sep 30, 2021 |
-1,178.95% |
| Mar 31, 2021 |
5.00% |
| Dec 31, 2020 |
844.34% |
